Our programs
Traumatic
Brain Injury
We develop molecules and an associated biomarker to cure immune deficiency after a traumatic brain injury
Our programs Anti-Infective
We develop new anti-infectives to cure chronic infections by destroying the bacteria at the root of the relapses
Our pilars We save lives
We develop new drugs to cure immune diseases and infections thanks to molecules discovered in algae.
Learn more
Our programs
Our pipeline: Delivering first-in-class immunotherapies of activation and regulation. We develop 2 different classes of therapeutic molecules in our 2 areas of expertise within our proprietary research platform: immunology and infectiology.
Our team
Olgram relies upon its international and complementary team of experts involved in research, drug development, pharmaceutical and industrial sucesses to develop the next immunotherapies.
